Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy ...

Retrieved on: 2021-06-01 22:18:45

Tags for this article:

Click the tags to see associated articles and topics

Belantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy .... View article details on hiswai:

Excerpt

Patients who become refractory to PIs, IMiDs, and monoclonal antibodies have an inferior outcome with a median OS of 5.6 months, so there is a ...

Article found on: www.dovepress.com